110 related articles for article (PubMed ID: 28730823)
1. Pathophysiological analysis of the progression of hepatic lesions in STAM mice.
Saito T; Muramatsu M; Ishii Y; Saigo Y; Konuma T; Toriniwa Y; Miyajima K; Ohta T
Physiol Res; 2017 Nov; 66(5):791-799. PubMed ID: 28730823
[TBL] [Abstract][Full Text] [Related]
2. Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis.
Yoshimine Y; Uto H; Kumagai K; Mawatari S; Arima S; Ibusuki R; Mera K; Nosaki T; Kanmura S; Numata M; Tamai T; Moriuchi A; Tsubouchi H; Ido A
Oncol Rep; 2015 Apr; 33(4):1657-66. PubMed ID: 25607821
[TBL] [Abstract][Full Text] [Related]
3. Analysis of amino acid profiles of blood over time and biomarkers associated with non-alcoholic steatohepatitis in STAM mice.
Iida A; Kuranuki S; Yamamoto R; Uchida M; Ohta M; Ichimura M; Tsuneyama K; Masaki T; Seike M; Nakamura T
Exp Anim; 2019 Nov; 68(4):417-428. PubMed ID: 31155606
[TBL] [Abstract][Full Text] [Related]
4. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis.
Saito K; Uebanso T; Maekawa K; Ishikawa M; Taguchi R; Nammo T; Nishimaki-Mogami T; Udagawa H; Fujii M; Shibazaki Y; Yoneyama H; Yasuda K; Saito Y
Sci Rep; 2015 Aug; 5():12466. PubMed ID: 26289793
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
[TBL] [Abstract][Full Text] [Related]
6. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
7. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
[TBL] [Abstract][Full Text] [Related]
8. Oral Administration of Mulberry (
Wakame K; Sato K; Kasai M; Kikuchi E; Shimizu K; Kudo A; Komatsu KI; Nakata A
Anticancer Res; 2022 Aug; 42(8):4055-4062. PubMed ID: 35896224
[TBL] [Abstract][Full Text] [Related]
9. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
Lytle KA; Jump DB
PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
[TBL] [Abstract][Full Text] [Related]
10. Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet.
Horai Y; Utsumi H; Ono Y; Kishimoto T; Ono Y; Fukunari A
Int J Exp Pathol; 2016 Feb; 97(1):75-85. PubMed ID: 27037502
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hepatic function using dynamic contrast-enhanced magnetic resonance imaging in melanocortin 4 receptor-deficient mice as a model of nonalcoholic steatohepatitis.
Yamada T; Kashiwagi Y; Rokugawa T; Kato H; Konishi H; Hamada T; Nagai R; Masago Y; Itoh M; Suganami T; Ogawa Y; Abe K
Magn Reson Imaging; 2019 Apr; 57():210-217. PubMed ID: 30465867
[TBL] [Abstract][Full Text] [Related]
12. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
13. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
14. Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis.
Mohamed RH; Tarek M; Hamam GG; Ezzat SF
Eur J Pharmacol; 2019 Sep; 858():172469. PubMed ID: 31233751
[TBL] [Abstract][Full Text] [Related]
15. Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis.
Kakehashi A; Chariyakornkul A; Suzuki S; Khuanphram N; Tatsumi K; Yamano S; Fujioka M; Gi M; Wongpoomchai R; Wanibuchi H
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802238
[TBL] [Abstract][Full Text] [Related]
16. Exercise restores bioavailability of hydrogen sulfide and promotes autophagy influx in livers of mice fed with high-fat diet.
Wang B; Zeng J; Gu Q
Can J Physiol Pharmacol; 2017 Jun; 95(6):667-674. PubMed ID: 28177674
[TBL] [Abstract][Full Text] [Related]
17. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice.
Kawai D; Takaki A; Nakatsuka A; Wada J; Tamaki N; Yasunaka T; Koike K; Tsuzaki R; Matsumoto K; Miyake Y; Shiraha H; Morita M; Makino H; Yamamoto K
Hepatology; 2012 Sep; 56(3):912-21. PubMed ID: 22505328
[TBL] [Abstract][Full Text] [Related]
19. Gut insulin action protects from hepatocarcinogenesis in diabetic mice comorbid with nonalcoholic steatohepatitis.
Soeda K; Sasako T; Enooku K; Kubota N; Kobayashi N; Ikushima YM; Awazawa M; Bouchi R; Toda G; Yamada T; Nakatsuka T; Tateishi R; Kakiuchi M; Yamamoto S; Tatsuno K; Atarashi K; Suda W; Honda K; Aburatani H; Yamauchi T; Fujishiro M; Noda T; Koike K; Kadowaki T; Ueki K
Nat Commun; 2023 Oct; 14(1):6584. PubMed ID: 37852976
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats.
Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
